United States · FDA National Drug Code directory

PIOGLITAZONE HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
76385-180_a41fecfd-4068-40ad-bc76-96c48ff32f5e
Product NDC
76385-180
Form
TABLET
Composition / generic term
PIOGLITAZONE HYDROCHLORIDE
Labeler
Unichem Pharmaceuticals (USA), Inc.
Marketing category
ANDA
Marketing start / end (source format)
20260625
Source listing expiry
20271231

Source-listed ingredients

  • PIOGLITAZONE HYDROCHLORIDE — 45 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1000 TABLET in 1 BOTTLE (76385-180-10) · 76385-180-10
  • 30 TABLET in 1 BOTTLE (76385-180-30) · 76385-180-30
  • 500 TABLET in 1 BOTTLE (76385-180-50) · 76385-180-50
  • 90 TABLET in 1 BOTTLE (76385-180-90) · 76385-180-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →